文献速递类风湿关节炎

类风湿关节炎相关DRB1*04:01分子、主要糖基化II型胶原肽与T细胞受体构成的三分子复合物的关键相互作用

Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor.
PubMed 文献 · Ann Rheum Dis · 2022-01-13

本研究在分子水平解析DRB1*04:01(HLA-DRA*01:01/HLA-DRB1*04:01)呈递翻译后修饰II型胶原(Col2)来源肽Col2259-273的自身抗原呈递功能。晶体结构显示肽与DRB1*04:01结合及侧链暴露,Col2259-273主要TCR识别位点为可半乳糖基化的赖氨酸残基。DRB1*04:01阳性RA患者T细胞对Col2259-273的应答依赖赖氨酸264的半乳糖基化,动态分子建模提示TCR对糖基化赖氨酸264的变构识别差异。

要点

  • DRB1*04:01呈递的半乳糖基化Col2259-273是RA T细胞识别的自身抗原决定簇。
  • Col2259-273主要TCR识别位点为可半乳糖基化的赖氨酸残基。
  • RA患者T细胞应答依赖Col2259-273赖氨酸264的半乳糖基化。

核心结论

  • 本研究阐明的MHC-肽-TCR相互作用为认识一种翻译后修饰的RA T细胞决定簇提供了新的分子层面见解,该决定簇在鼠Col2诱导关节炎的致关节炎与致耐受应答中具有已知的主导作用。

研究设计与样本

  • 研究解析了DRB1*04:01分子与肽HSP70289-306、瓜氨酸化CILP982-996及半乳糖基化Col2259-273共结晶的晶体结构。
  • 研究通过流式细胞术检测肽刺激后活化标志物CD154及荧光DRB1*0401/Col2259-273四聚体复合物结合,在DRB1*04:01阳性RA患者外周血单个核细胞中检测Col2259-273特异性T细胞。
  • 研究从单细胞分选的四聚体阳性T细胞克隆TCR α链与β链cDNA,并经慢病毒载体转入TCR缺陷的Jurkat 76细胞。

主要发现

  • 晶体结构识别了肽与DRB1*04:01的结合及潜在的侧链向T细胞暴露。
  • Col2259-273的主要TCR识别位点为可半乳糖基化的赖氨酸残基。
  • RA T细胞对DRB1*04:01呈递的Col2259-273的应答依赖赖氨酸264处的肽半乳糖基化。
  • 对功能表征的Col2259-273特异性TCR与DRB1*04:01/Col2259-273复合物的动态分子建模,提供了TCR对糖基化赖氨酸264变构识别差异的证据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rheumatoid arthritis (RA) is an autoimmune disease strongly associated with the major histocompatibility complex (MHC) class II allele DRB1*04:01, which encodes a protein that binds self-peptides for presentation to T cells. This study characterises the autoantigen-presenting function of DRB1*04:01 (HLA-DRA*01:01/HLA-DRB1*04:01) at a molecular level for prototypic T-cell determinants, focusing on a post-translationally modified collagen type II (Col2)-derived peptide. METHODS: The crystal structures of DRB1*04:01 molecules in complex with the peptides HSP70289-306, citrullinated CILP982-996 and galactosylated Col2259-273 were determined on cocrystallisation. T cells specific for Col2259-273 were investigated in peripheral blood mononuclear cells from patients with DRB1*04:01-positive RA by cytofluorometric detection of the activation marker CD154 on peptide stimulation and binding of fluorescent DRB1*0401/Col2259-273 tetramer complexes. The cDNAs encoding the T-cell receptor (TCR) α-chains and β-chains were cloned from single-cell sorted tetramer-positive T cells and transferred via a lentiviral vector into TCR-deficient Jurkat 76 cells. RESULTS: The crystal structures identified peptide binding to DRB1*04:01 and potential side chain exposure to T cells. The main TCR recognition sites in Col2259-273 were lysine residues that can be galactosylated. RA T-cell responses to DRB1*04:01-presented Col2259-273 were dependent on peptide galactosylation at lysine 264. Dynamic molecular modelling of a functionally characterised Col2259-273-specific TCR complexed with DRB1*04:01/Col2259-273 provided evidence for differential allosteric T-cell recognition of glycosylated lysine 264. CONCLUSIONS: The MHC-peptide-TCR interactions elucidated in our study provide new molecular insights into recognition of a post-translationally modified RA T-cell determinant with a known dominant role in arthritogenic and tolerogenic responses in murine Col2-induced arthritis.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Ge C, Weisse S, Xu B, et al. Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor. Ann Rheum Dis. 2022. PMID: 35027402. doi:10.1136/annrheumdis-2021-220500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。